Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome
Authors:
- Ramin AlemzadehRARamin Alemzadeh
- Jessica KichlerJKJessica Kichler
- Mariaelena CalhounMCMariaelena Calhoun
- 1 June 2010
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 162 (6) , 1093-1099
Abstract
Objective: Polycystic ovary syndrome (PCOS) in adult women is associated with increased risk of metabolic syndrome (MS) and atherosclerosis. We evaluated the spectrum of metabolic dysfunction in relationship with hyperandrogenemia (HA) in adolescent girls with PCOS.Materials and methods: Ovulatory function, acne, hirsutism (HS), body mass index (BMI), body composition, fasting lipids, glucose, insulin, free testosterone (FT), high-sensitivity C-reactive protein (hs-CRP), and HbA1c were evaluated in 103 girls. The homeostatic assessment model equations (HOMA-IR and HOMA-%B) were used for determination of insulin resistance and β-cell function respectively.Results: The oligo-ovulation (Oligo)+HA+HS (n=44), Oligo+HA (n=28), and Oligo+HS (n=31) phenotypes had similar BMI. However, hyperandrogenemic phenotypes had higher prevalence of acanthosis nigricans (AN) and acne (PPr=0.38,Pr=0.49,Pr=0.42,Pr=0.39,Pr=0.27,PP3.0 cut-off values, 71.4% of MS versus 23.5% non-MS group were considered at risk of diabetes and atherosclerosis (P<0.0001).Conclusions: Hyperandrogenemic PCOS phenotypes have greatest degree of insulin resistance and inflammation. The use of insulin resistance and inflammatory markers may help identify adolescent girls with PCOS at risk of cardiometabolic syndrome.Keywords
This publication has 42 references indexed in Scilit:
- Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levelsFertility and Sterility, 2009
- Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOSClinical Endocrinology, 2007
- Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroupsFertility and Sterility, 2005
- Polycystic Ovary SyndromeNew England Journal of Medicine, 2005
- The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected PopulationThe Journal of Clinical Endocrinology & Metabolism, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?Endocrine Reviews, 2003
- Polycystic ovary syndrome and endometrial carcinomaThe Lancet, 2003
- A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic ProfileThe Journal of Clinical Endocrinology & Metabolism, 1999
- Androgen Response to Endogenous Insulin Secretion during the Frequently Sampled Intravenous Glucose Tolerance Test in Normal and Hyperandrogenic Women*The Journal of Clinical Endocrinology & Metabolism, 1990